Show simple item record

dc.contributor.authorGreider, Carol W.
dc.contributor.authorFeldser, David M.
dc.date.accessioned2009-11-30T19:22:10Z
dc.date.available2009-11-30T19:22:10Z
dc.date.issued2007-05
dc.identifier.citationReprinted from Cancer Cell 11, Feldser, David M. and Carol W. Greider, "Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence", pg. 461-469, copyright 2001 with permission from Elsevier. Original version available at http://www.cell.comen
dc.identifier.urihttp://jhir.library.jhu.edu/handle/1774.2/33685
dc.description.abstractTelomere maintenance is critical for cancer progression. To examine mechanisms of tumor suppression induced by short telomeres, we crossed mice deficient for the RNA component of telomerase, mTR(-/-), with Emu-myc transgenic mice, an established model of Burkitt's lymphoma. Short telomeres suppressed tumor formation in Emu-myc transgenic animals. Expression of Bcl2 blocked apoptosis in tumor cells, but surprisingly, mice with short telomeres were still resistant to tumor formation. Staining for markers of cellular senescence showed that pretumor cells induced senescence in response to short telomeres. Loss of p53 abrogated the short telomere response. This study provides in vivo evidence for the existence of a p53-mediated senescence mechanism in response to short telomeres that suppresses tumorigenesis.en
dc.language.isoen_USen
dc.publisherCell Pressen
dc.subjectTelomereen
dc.subjectCell Aging/geneticsen
dc.subjectBurkitt Lymphoma/geneticsen
dc.titleShort Telomeres Limit Tumor Progression In Vivo by Inducing Senescenceen
dc.typeArticleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record